Health1 hour ago
Sinful 😈•60%
FSSAI Flags Nestle Infant Products for Misleading Claims
FSSAI has raised concerns over Nestle's infant products due to misleading promotional claims and biotin levels. The regulatory body emphasizes the need for accurate labeling to ensure consumer safety. Nestle's response and potential implications for the brand's reputation are under scrutiny as parents seek reliable nutrition for their children.
⚖️ AI Verdict
"Nestle might want to double-check their baby food marketing!"
📢 Share Intel:
File ID: #396117Original Source: Times Of India ↗
🤖 SINS Investigator
Ask about this Intel File
🕵️♂️
File Opened for Analysis
Ask me anything about the event, its implications, or who is responsible for the SINS!
Deepen Investigation
Related Intelligence Files
Health1 hour ago
Andhra Pradesh Achieves 86 in Patient Safety, Leading India
Andhra Pradesh leads India in patient safety with a score of 86, according to the Health Department. The state has completed inspections in all 62 area and district hospitals, achieving a 65% certification rate under the National Quality Assurance Scheme. This accomplishment highlights the state's commitment to improving healthcare quality and patient safety standards.
View File→
Health7 hours ago
Mumbai's Olympia Coffee House Loses License Over Hygiene Violations
Olympia Coffee House in Mumbai's Colaba loses its food license due to severe hygiene violations, including a urinal found in the food storage area. The inspection revealed unsanitary conditions, leading to the suspension of licenses for seven other establishments, including Vishwas Sweets and Snacks. State authorities also seized milk and dairy products worth over Rs 7, highlighting ongoing food safety concerns in the region.
View File→
Health7 hours ago
FDA Suspends Café Mondegar License Amid Mumbai Food Safety Crackdown
The FDA has suspended Café Mondegar's license due to food safety violations. This action is part of a broader enforcement initiative targeting eateries in Greater Mumbai during the festival season. The crackdown, which took place from September 11 to 14, aims to ensure compliance with health regulations across the city.
View File→
Health7 hours ago
FDA Chief Tukaram Highlights Price Gaps in Medical Devices
FDA Chief Tukaram has raised concerns over significant price discrepancies in medical devices, urging government intervention. A recent report revealed that an IV set costing ₹11.05 had a marked price of ₹325, while an infusion set was bought for ₹11 but had an MRP of ₹201. This alarming gap in pricing raises questions about transparency and regulation in the medical device industry.
View File→